Contract

Primary Care Pathway for Tirzepatide Lambeth

  • NHS South East London Integrated Care Board

F03: Contract award notice

Notice identifier: 2025/S 000-081973

Procurement identifier (OCID): ocds-h6vhtk-05f3cd

Published 11 December 2025, 1:00pm



Section one: Contracting authority

one.1) Name and addresses

NHS South East London Integrated Care Board

London

Email

hub.queries@nhs.net

Country

United Kingdom

Region code

UKI45 - Lambeth

Justification for not providing organisation identifier

Not on any register

Internet address(es)

Main address

https://www.selondonics.org/icb/

Buyer's address

https://www.selondonics.org/icb/

one.4) Type of the contracting authority

Body governed by public law

one.5) Main activity

Health


Section two: Object

two.1) Scope of the procurement

two.1.1) Title

Primary Care Pathway for Tirzepatide Lambeth

Reference number

PRN01624

two.1.2) Main CPV code

  • 85100000 - Health services

two.1.3) Type of contract

Services

two.1.4) Short description

To ensure patients starting tirzepatide (Mounjaro®) receive holistic, person-centred care that includes Behavioural Support for Obesity Prescribing (BSOP) commissioed by NHSE (Lambeth)

Being awarded as any delay to the award would significantly extend the timeline for the nationally mandated Mounjaro rollout, with attendant risks to the health of the eligible cohort.

two.1.6) Information about lots

This contract is divided into lots: No

two.1.7) Total value of the procurement (excluding VAT)

Value excluding VAT: £77,520

two.2) Description

two.2.2) Additional CPV code(s)

  • 85100000 - Health services

two.2.3) Place of performance

NUTS codes
  • UKI - London
Main site or place of performance

Lambeth Healthcare Ltd

Akerman Health Centre 60 Patmos Road, London

SW9 6AF

two.2.4) Description of the procurement

To ensure patients starting tirzepatide (Mounjaro®) receive holistic, person-centred care that includes Behavioural Support for Obesity Prescribing (BSOP) commissioed by NHSE.

Being awarded as any delay to the award would significantly extend the timeline for the nationally mandated Mounjaro rollout, with attendant risks to the health of the eligible cohort.

two.2.5) Award criteria

Price

two.2.11) Information about options

Options: No

two.2.14) Additional information

This is a Provider Selection Regime (PSR) intention to award notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to this award. The publication of this notice marks the start of the standstill period.

Award decision makers: South East London Integrated Care Board

There were no conflict of interest identified in the decision making process.

An urgent award or modification is to be made by the relevant authority as the following are true:

• The award or modification must be made urgently.

• The reason for the urgency was not foreseeable by and is not attributable to the relevant authority.

• Delaying the award to conduct a full application of the PSR would be likely to pose a risk to patient or public safety.

Urgent award is required as any delay to the award would significantly extend the timeline for the nationally mandated Mounjaro rollout, with attendant risks to the health of the eligible cohort.


Section four. Procedure

four.1) Description

four.1.1) Type of procedure

Award of a contract without prior publication of a call for competition in the cases listed below

  • No tenders or no suitable tenders/requests to participate in response to open procedure

Explanation:

Award of a contract without prior publication of a call for competition. An Urgent award is required.

Any delay to the award would significantly extend the timeline for the nationally mandated Mounjaro rollout, with attendant risks to the health of the eligible cohort.

four.1.8) Information about the Government Procurement Agreement (GPA)

The procurement is covered by the Government Procurement Agreement: Yes


Section five. Award of contract

A contract/lot is awarded: Yes

five.2) Award of contract

five.2.1) Date of conclusion of the contract

11 December 2025

five.2.2) Information about tenders

Number of tenders received: 1

The contract has been awarded to a group of economic operators: No

five.2.3) Name and address of the contractor

Lambeth Healthcare Ltd

Akerman Health Centre 60 Patmos Road

London

SW9 6AF

Country

United Kingdom

NUTS code
  • UKI45 - Lambeth
Justification for not providing organisation identifier

Not on any register

The contractor is an SME

No

five.2.4) Information on value of contract/lot (excluding VAT)

Total value of the contract/lot: £77,520


Section six. Complementary information

six.3) Additional information

This is a Provider Selection Regime (PSR) intention to award notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to this award. The publication of this notice marks the start of the standstill period.

Award decision makers: South East London Integrated Care Board

There were no conflict of interest identified in the decision making process.

An urgent award or modification is to be made by the relevant authority as the following are true:

• The award or modification must be made urgently.

• The reason for the urgency was not foreseeable by and is not attributable to the relevant authority.

• Delaying the award to conduct a full application of the PSR would be likely to pose a risk to patient or public safety.

An urgent award is required as any delay to the award would significantly extend the timeline for the nationally mandated Mounjaro rollout, with attendant risks to the health of the eligible cohort

six.4) Procedures for review

six.4.1) Review body

NHS South East London Integrated Care Board

London

Country

United Kingdom